Holen Sie sich die Stockscreener-App
201.93
0.14%
0.1699
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca Plc Aktie (AZN) Neueste Nachrichten
AstraZeneca PLC $AZN Position Lessened by Teachers Retirement System of The State of Kentucky - MarketBeat
AstraZeneca (AZN) Strengthens Clinical Portfolio and Expands Inv - GuruFocus
CDT Positions for Transformational Growth - Benzinga
GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.
CI Investments Inc. Has $18.33 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca’s Tezepelumab Study Targets Real-World Gains in Chronic Sinus Disease - TipRanks
AstraZeneca (AZN) adds three fixed-rate US dollar note issues out to 2036 - Stock Titan
AstraZeneca PLC (AZN) Investor Outlook: Evaluating the Healthcare Giant Amidst a -21.01% Potential Downside - DirectorsTalk Interviews
Morqan Stanley Raises Astrazeneca Price Target to $219 From $109, Overweight Rating Kept - marketscreener.com
AstraZeneca reports total voting rights of over 1.55 billion shares - Investing.com
AstraZeneca (LSE/STO/NYSE: AZN) details 1.55B voting rights - Stock Titan
Fisher Asset Management LLC Acquires 466,745 Shares of AstraZeneca PLC $AZN - MarketBeat
Rafferty Asset Management LLC Sells 7,892 Shares of AstraZeneca PLC $AZN - MarketBeat
Becker Capital Management Inc. Decreases Position in AstraZeneca PLC $AZN - MarketBeat
Antibiotics Market - GlobeNewswire Inc.
American Century Companies Inc. Has $167.79 Million Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC (AZN.L) Stock Report: Analyzing a Healthcare Powerhouse with a $241 Billion Market Cap - DirectorsTalk Interviews
AstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
AstraZeneca PLC $AZN Shares Bought by US Bancorp DE - MarketBeat
Harvest Portfolios Group Inc. Sells 20,219 Shares of AstraZeneca PLC $AZN - MarketBeat
AlphaCore Capital LLC Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Acquired by TD Asset Management Inc - MarketBeat
Erste Asset Management GmbH Sells 29,313 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange - FinancialContent
Thornburg Investment Management Inc. Sells 24,703 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca has 'sector leading replacement power' to cope with 2030 patent cliff - Proactive financial news
AstraZeneca (AZN) prices $2bn in new fixed-rate global bond tranches - Stock Titan
AstraZeneca prices $2 bln bond offering - marketscreener.com
Primecap Management Co. CA Sells 1,342,120 Shares of AstraZeneca PLC $AZN - MarketBeat
RWA Wealth Partners LLC Purchases 6,444 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLCAstraZeneca prices a $2bn bond offering - Research Tree
AstraZeneca Prices Three-tranche Global Bond Issue Worth $2 Billion - marketscreener.com
REGAstraZeneca PLCAstraZeneca prices a $2bn bond offering - TradingView
AstraZeneca’s Soriot Rewarded With $23m Pay But Still Lags Behind US Peers - Citeline News & Insights
AstraZeneca Advances Subcutaneous Durvalumab Study, Targeting More Convenient Cancer Care - TipRanks
Astrazeneca files 2025 annual report on Form 20-F with SEC - Investing.com
Astrazeneca files 2025 annual report on Form 20-F with SEC By Investing.com - Investing.com South Africa
Compound Planning Inc. Has $2.53 Million Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Medicines: Oncology Portfolio and Pipeline - AstraZeneca
Assessing AstraZeneca (LSE:AZN) Valuation After Strong Recent Share Price Momentum - simplywall.st
[6-K] ASTRAZENECA PLC Current Report (Foreign Issuer) | AZN SEC FilingForm 6-K - Stock Titan
AstraZeneca (AZN) files Iran‑related disclosure in 20‑F annual report - Stock Titan
AstraZeneca Drug Price Challenge Falls Short In Hawaii - Law360
AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025 - Yahoo Finance UK
AstraZeneca’s CLARITY-Gastric 02 Trial Targets New Front in Stomach Cancer - TipRanks
AstraZeneca Fails in Bid to Halt Hawaii 340B Drug Delivery Law - Bloomberg Law News
AstraZeneca publishes 2025 annual financial report and sets AGM for April - Investing.com South Africa
AstraZeneca announces board changes as Nazneen Rahman to retire in April By Investing.com - Investing.com South Africa
AstraZeneca announces board changes as Nazneen Rahman to retire in April - Investing.com
AstraZeneca (AZN) publishes 2025 Annual Report and sets 9 April 2026 AGM - Stock Titan
AstraZeneca (AZN) outlines non-executive board and committee changes - Stock Titan
AstraZeneca PLC Announces Directorate And Committee Changes, Effective April 9, 2026 - marketscreener.com
AstraZeneca boosts CEO Soriot's pay to about $24 million for 2025 - marketscreener.com
AstraZeneca announces retirement of non-executive director Nazneen Rahman - marketscreener.com
BRIEF-AstraZeneca Announces Retirement Of Non-Executive Director Nazneen Rahman - Devdiscourse
AstraZeneca : Directorate change - marketscreener.com
Transatlantique Private Wealth LLC Takes Position in AstraZeneca PLC $AZN - MarketBeat
Zevin Asset Management LLC Sells 7,994 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Vestmark Advisory Solutions Inc. - MarketBeat
Legacy Financial Advisors Inc. Invests $1.06 Million in AstraZeneca PLC $AZN - MarketBeat
FDA Gives Green Light to AstraZeneca's All-Oral Calquence-Venetoclax Combo for CLL - StockInvest.us
Marks Group Wealth Management Inc Buys 5,896 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Purchased by Bleakley Financial Group LLC - MarketBeat
Westerkirk Capital Inc. Invests $906,000 in AstraZeneca PLC $AZN - MarketBeat
0.06%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):